Evidence map›Paper›PMID 18690981›Full record

ReviewCurrent drug safety2008

Lead encephalopathy due to traditional medicines.

Surya K Karri, Robert B Saper, Stefanos N Kales

Open access · greenAbstract readReview
In one paragraph

Review in Current drug safety, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Reducing lead toxicity with advanced nanotechnology methods.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer's disease.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Review
  9. Article
  10. Article
  11. Unusual Domestic Source of Lead Poisoning.International journal of environmental research and public health · 2020
    Article
  12. Article
  13. Lead: Tiny but Mighty Poison.Indian journal of clinical biochemistry : IJCB · 2018
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effects of Lead in Various Preparatory Stages ofJournal of clinical and diagnostic research : JCDR · 2016
    Article
  19. Lead toxicity: a review.Interdisciplinary toxicology · 2015
    Review
  20. A cluster of lead poisoning among consumers of Ayurvedic medicine.International journal of occupational and environmental health · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Surya K KarriDepartment of Family Medicine, Boston University Medical Center, 1 Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA. Surya.Karri@bmc.org
Robert B Saper
Stefanos N Kales
Boston Medical Center · US

Funding

Academic Career Development in CAM Research and EducationK07AT002915 · NCCIH · BOSTON MEDICAL CENTER · PI SAPER, ROBERT BRUCE · 2005 to 2009
$642k
NCCIH NIH HHS K07 AT002915
6 · The paper itself

Abstract

Traditional medicine use is common in developing countries and increasingly popular in the western world. Despite the popularity of traditional medicines, scientific research on safety and efficacy is limited. However documented fatalities and severe illness due to lead poisoning are increasingly recognized to be associated with traditional medicine use. As society becomes more globalized, it is imperative for pharmacists and health care providers to learn about the safety of traditional medical practices. The information presented educates and alerts pharmacists and health care providers about the potential of traditional medicines to cause lead encephalopathy. Case reports were located through systematic literature searches using MEDLINE, CINAHL, AMED, CISCOM, EMBASE and The Cochrane library from 1966 to the February 2007. Reference lists of identified articles and the authors' own files were also searched. Inclusion criteria were cases of human lead encephalopathy associated with traditional medical practices. There were no restrictions regarding the language of publication. Data were subsequently extracted and summarized in narrative and tabular form. We found 76 cases of lead encephalopathy potentially associated with traditional medicine. Ayurvedic medicines were associated with 5 cases (7%), Middle eastern traditional medicines with 66 cases (87%) and 5 cases (7%) with other traditional medicines. Of the 76 cases, 5% were in adults and 95% were in infants and young children. Of the 4 adult cases, at least one was left with residual neurological impairment. In infants and young children, among 72 cases 8 (11%) were fatal, and at least 15 (21%) had residual neurological deficits. Traditional medicine users should be screened for lead exposure and strongly encouraged to discontinue metal-containing remedies. Therefore, the United States Food and Drug Administration and corresponding agencies in other countries should require and enforce heavy metal testing for all imported traditional medicines and "dietary supplements".

Indexed as

Medicine, TraditionalAdultAnimalsChildHumansLatin AmericaLeadLead Poisoning, Nervous SystemMedicine, AyurvedicMedicine, Chinese TraditionalMiddle EastLead

Identifiers

PMID18690981
PMCPMC2538609
OpenAlexW2161718730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.